v3.26.1
Stockholders' Equity (Deficit) (Details)
3 Months Ended 6 Months Ended
Apr. 06, 2026
Oct. 08, 2025
$ / shares
shares
Mar. 23, 2025
USD ($)
$ / shares
shares
Dec. 02, 2024
USD ($)
$ / shares
shares
Jul. 22, 2024
USD ($)
$ / shares
shares
Jan. 22, 2024
USD ($)
$ / shares
shares
Mar. 31, 2025
shares
Jun. 30, 2025
USD ($)
Jun. 30, 2026
$ / shares
shares
Mar. 31, 2026
shares
Mar. 02, 2026
shares
Dec. 31, 2025
$ / shares
shares
Oct. 31, 2025
shares
Jan. 31, 2024
$ / shares
shares
Stockholders' Equity (Deficit)                            
Maximum number of shares which the Company is authorized to issue                 300,000,000          
Preferred stock, par value (in dollars per share) | $ / shares                 $ 0.0001          
Common stock, shares issued                 1,011,595     916,968    
Common stock, share outstanding                 1,011,595     916,968    
Preferred Stock, Shares Issued                 1,215,670     1,436    
Preferred stock, shares outstanding                 1,215,670     1,436    
Number of preferred shares authorized                 8,784,330          
Minimum percentage of preferred stock required for approval   30.00%                        
Minimum advance notice period   60 days                        
Percentage of share consideration   100.00%                        
Net proceeds from sales of common stock | $               $ 8,854,797            
January Placement Agent Warrants                            
Stockholders' Equity (Deficit)                            
Number of shares purchased by exercise of warrants                 388         388
Term of warrants                           3 years 6 months
Exercise price | $ / shares                 $ 1,409.1         $ 1,409.1
Series C warrants                            
Stockholders' Equity (Deficit)                            
Number of shares purchased by exercise of warrants                 144,682          
Term of warrants       5 years                    
Exercise price | $ / shares                 $ 348.35          
Series D warrants                            
Stockholders' Equity (Deficit)                            
Term of warrants       2 years 6 months                    
March 2025 Offering Warrants                            
Stockholders' Equity (Deficit)                            
Number of shares purchased by exercise of warrants     366,080           366,080          
Term of warrants     5 years                      
Exercise price | $ / shares     $ 24.08           $ 24.08          
March 2025 Placement Agents Warrants                            
Stockholders' Equity (Deficit)                            
Number of shares purchased by exercise of warrants     18,290           18,290          
Term of warrants     5 years                      
Exercise price | $ / shares     $ 29.96           $ 29.96          
Securities Purchase Agreement                            
Stockholders' Equity (Deficit)                            
Aggregate of direct offering           465                
Price per share (in dollars per share) | $ / shares           $ 1,127.28                
Net proceeds from sales of common stock | $           $ 6,100,000                
Securities Purchase Agreement | Pre-funded warrants                            
Stockholders' Equity (Deficit)                            
Number of warrants sold           5,968                
Price per share (in dollars per share) | $ / shares           $ 1,118.04                
Exercise price | $ / shares           $ 9.24                
Securities Purchase Agreement | January Warrants                            
Stockholders' Equity (Deficit)                            
Number of warrants sold           12,864                
Term of warrants           3 years 6 months                
Exercise price | $ / shares           $ 1,127.28                
Securities Purchase Agreement | January Placement Agent Warrants                            
Stockholders' Equity (Deficit)                            
Number of shares purchased by exercise of warrants           388                
Term of warrants           3 years 6 months                
Exercise price | $ / shares           $ 1,409.1                
Securities Purchase Agreement | Series C warrants                            
Stockholders' Equity (Deficit)                            
Number of warrants sold       22,966                    
Exercise price | $ / shares       $ 348.35                    
Securities Purchase Agreement | Series D warrants                            
Stockholders' Equity (Deficit)                            
Number of warrants sold       22,966                    
Exercise price | $ / shares       $ 348.35                    
Purchase of common stock                 3          
December 2024 Offering                            
Stockholders' Equity (Deficit)                            
Issuance of stock, net of issuance costs (in shares)       6,180                    
Price per share (in dollars per share) | $ / shares       $ 348.35                    
Net proceeds from sales of common stock | $       $ 7,200,000                    
December 2024 Offering | Pre-funded warrants                            
Stockholders' Equity (Deficit)                            
Number of warrants sold       16,786                    
Price per share (in dollars per share) | $ / shares       $ 348.25                    
December 2024 Offering | Series C warrants                            
Stockholders' Equity (Deficit)                            
Number of warrants sold       22,966                    
Term of warrants       5 years                    
Exercise price | $ / shares       $ 348.35                    
December 2024 Offering | Series D warrants                            
Stockholders' Equity (Deficit)                            
Number of warrants sold       22,966                    
Term of warrants       2 years 6 months                    
Exercise price | $ / shares       $ 348.350                    
Purchase of common stock       3                    
July 2024 Offering                            
Stockholders' Equity (Deficit)                            
Issuance of stock, net of issuance costs (in shares)         10,823                  
Price per share (in dollars per share) | $ / shares         $ 277.2                  
Net proceeds from sales of common stock | $         $ 2,400,000                  
July 2024 Offering | July Placement Agent Warrants                            
Stockholders' Equity (Deficit)                            
Number of shares purchased by exercise of warrants         548                  
Exercise price | $ / shares         $ 346.5                  
March 2025 Registered Direct Offering                            
Stockholders' Equity (Deficit)                            
Issuance of stock, net of issuance costs (in shares)     366,080                      
Price per share (in dollars per share) | $ / shares     $ 27.44                      
Net proceeds from sales of common stock | $     $ 8,900,000                      
March 2025 Registered Direct Offering | March 2025 Offering Warrants                            
Stockholders' Equity (Deficit)                            
Number of shares purchased by exercise of warrants     366,080                      
Exercise price | $ / shares     $ 24.08                      
March 2025 Registered Direct Offering | March 2025 Placement Agents Warrants                            
Stockholders' Equity (Deficit)                            
Number of shares purchased by exercise of warrants     18,290                      
Exercise price | $ / shares     $ 29.96                      
Series C Preferred Stock                            
Stockholders' Equity (Deficit)                            
Preferred stock, par value (in dollars per share) | $ / shares                 $ 0.0001     $ 0.0001    
Preferred stock, shares authorized                 1,214,204   1,214,204 0    
Preferred Stock, Shares Issued                 1,214,204   1,214,204 0    
Preferred stock, shares outstanding                 1,214,204     0    
Preferred stock conversion ratio                     1      
Series B Preferred Stock                            
Stockholders' Equity (Deficit)                            
Preferred stock, par value (in dollars per share) | $ / shares                 $ 0.0001     $ 0.0001    
Preferred stock, shares authorized                 223.7337     223.7337 223.7337  
Preferred Stock, Shares Issued                 223.7337     223.7337    
Preferred stock, shares outstanding                 223.7337     223.7337    
Preferred stock conversion ratio   100                        
Number of business days   2 days                        
Issuance of stock, net of issuance costs (in shares)   223.7337                        
Series A Preferred Stock                            
Stockholders' Equity (Deficit)                            
Preferred stock, par value (in dollars per share) | $ / shares   $ 0.0001                        
Temporary Equity, Shares Authorized                 1,242.0717     1,242.0717 1,242.0718  
Temporary Equity, Shares Issued                 1,242.0717     1,242.0717    
Temporary Equity, Shares Outstanding                 1,242.0717     1,212.1822    
Preferred paid-in-kind dividend, percentage 5.00%                          
Preferred stock conversion ratio   100                        
Number of business days   2 days                        
Number of new stock classified as temporary equity   1,212.1822                        
Common Stock                            
Stockholders' Equity (Deficit)                            
Maximum number of shares which the Company is authorized to issue                 290,000,000          
Issuance of stock, net of issuance costs (in shares)             796,930              
Preferred Stock                            
Stockholders' Equity (Deficit)                            
Maximum number of shares which the Company is authorized to issue                 10,000,000          
Preferred Stock | Series A Preferred Stock                            
Stockholders' Equity (Deficit)                            
Temporary Equity, Shares Outstanding                 1,242.0717 1,212.1822   1,212.1822